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In the presence of humoral antibody directed against grafts  of various tu- 
mors, hosts syngeneic with the tumors may reject the grafts  (1). We have re- 
ported that an intact complement system is not required for antibody-mediated 
suppression  of  certain  syngeneic murine lymphoma grafts.  A  radiosensitive 
host factor(s), however, is (are)  involved in this reaction as evidenced by the 
failure of irradiated hosts to suppress grafts that had been admixed with spe- 
cific alloantibody (2). 
The present report concerns the  delineation of  a  host  factor(s)  involved in 
antibody-mediated suppression of grafts  of  the  C3H  lymphoma 6C3HED  in 
C3HeB/J mice. Various C3HeB normal cell populations and sera were assayed 
for their capacity to restore suppressive ability to irradiated mice. 
Materials and Methods 
Details on the mice of inbred strains C3HeB/FJ and C57BL/6J  (abbreviated B6), 1 C3H 
lymphoma 6C3HED, B6 anti-6C3HED  serum, and whole body X-irradiation  are found in 
reference 2. 
Normal Donor Cells (NDC).--Isolated thymus, spleen, or lymph nodes from C3HeB mice 
were transferred to a Duall glass homogenizer (Kontes Glass Co., Vineland, N. J.) which con- 
tained  Hanks' balanced salt solution plus 0.1% glucose and 0.01% bovine serum albumin 
(HBG) at room temperature in a volume more than ten times that of the organs. The organs 
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were disrupted by one or two rotating thrusts of the plunger. The free cells were decanted to 
a centrifuge tube and were washed once by centrifugation in HBG. The pellet was dispersed 
in fresh HBG and 3 min were allowed for clumps to settle. The top two-thirds of the suspen- 
sion was aspirated and its cell concentration was adjusted in HBG to the desired value. Mar- 
row was flushed out from femurs with HBG containing 5 units of heparin/ml  (HBGH) and 
was dispersed in a homogenizer. After two washes by centrifugation in HRG the cell pellet 
was dispersed in HBG. 
For cells from the peritoneal cavity, 5 ml of HBGH were injected intraperitoneallv in a 
killed mouse. After the mouse was shaken gently, the fluid was aspirated  and its cells were 
washed twice in HBG. Six categories of donors were used:  (a)  normal mice; (b)  normal mice 
given 3 ml each of beef infusion broth intraperitoneally 2 days before cell harvest; (c) normal 
mice given 3 ml each of beef infusion broth intraperitoneally 4 days before cell harvest;  (d) 
mice given 3 ml each of 2.95% thioglycollate (Difco Laboratories, Inc., Detroit, Mich.) intra- 
peritoneally 6 days before cell harvest;  (e)  mice treated as in category (c)  except that they 
were given 500 R whole body irradiation 20 hr before cell harvest; (f) as in category (d) except 
mice were given 500 R whole body irradiation 20 hr before cell harvest. 
Cultured Macrophages.--The method described in reference 3 was used to culture the cells 
from category (b) mentioned above. Cell viability was 87% by dye exclusion. 
Experimental Tumor Grafting.--Tumor cells were harvested from C3H mice as described 
(2) and the cell count was adjusted to 8 X  106/ml HBG. For injection, aliquots of the tumor 
cell suspension  were mixed in equal volume with normal serum or antiserum  that had been 
diluted 1/2.5 with HBG, the mixtures being kept in crushed ice. After 15 rnin and with fre- 
quent shaking,  two parts of HBG alone or HBG containing NDC were mixed with one part 
of each  tumor  cell suspension.  Immediately thereafter 0.05  ml of the suspension  (i.e.,  105 
tumor cells plus varying numbers of NDC) was inoculated in one calf muscle of each mouse. 
Graft growth was followed by daily caliper measurement, as described (2). 
RESULTS 
Sensitivity  of  Mice  to  X-Irradiation.--As  reported  previously  (2)  tumor 
growth  was  not  inhibited  in  C3HeB  mice  given  whole  body  irradiation  and 
inoculated  1  day  later  with  6C3HED  cells  admixed  with  anti-graft  alloanti- 
body.  This was in contrast  to successful suppression  in nonirradiated  mice. At 
400 R  loss of suppressive  capacity was  inconsistent  but  at  500  R  or above all 
mice were incapacitated. 
For  a  kinetic  study  of  loss  and  recovery  of  suppressive  ability,  groups  of 
mice  exposed  to  500  R  were  challenged  at  various  time  intervals  thereafter 
with  tumor  alone or tumor  admixed with antibody  ("sensitized" tumor).  Loss 
of capacity was most prevalent in mice inoculated  1 or 2  days after irradiation 
(Fig.  1 B); there was a  marked loss of ability with an interval as short  as 3 hr. 
By 3  days recovery was  complete. In subsequent  experiments,  therefore, mice 
were challenged with tumor  1 day after irradiation. 
Restoration  of  Activity  with  NDC.--Tumor  cells,  sensitized  or  not,  were 
mixed with NDC  and  inoculated  into  irradiated  hosts.  Growth  of  the  tumors 
was followed by daily measurement.  Tumor size on day  11  after inoculation is 
tabulated in Table I. Only peritoneal cells restored suppressive capacity. These 
cells, however, varied in their  "curative" potential.  In three additional  experi- 
ments  peritoneal  cells from untreated  mice gave two partial  successes  and one SHIN,  KALISS~ BORENSTEIN,  AND  GATELY  377 
failure. In  contrast,  peritoneal exudate  cells induced  either by beef broth  or 
thioglycollate  consistently  restored  suppressive  capacity.  In  four  separate 
experiments  spleen,  thymus,  lymph  node,  or marrow  cells,  separately or  in 
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FIG. 1.  Growth of 6C3HED  grafts in calf muscles  of C3HeB  females  (five per group). 
Abbreviations: AS,  tumor  inoculum  admixed with  anti-tumor alloantiserum; NS,  tumor 
inoculum admixed with normal serum; P, peritoneal cells from normal C3HeB mice; IP, peri- 
toneal cells from irradiated donors; T, tumor cells. (A) Graft growth in nonirradiated hosts. 
(B) Kinetics of host recovery from irradiation-induced incapacitation for graft suppression. 
Curves show growth rates for grafts inoculated at 3 hr and at various days after irradiation. 
(C) Graft growth in mice given whole body irradiation 24 hr before tumor inoculation. Tumor 
inocula admixed with cultured peritoneal macrophages.  Ratio of tumor  cells to  admixed 
peritoneal cells given in parentheses.  (D) Graft growth in mice given whole body irradiation 
24 hr before  tumor inoculation.  Tumor inocula admixed  with thioglycollate induced peri- 
toneal exudate cells from normal or irradiated donors. Ratio of tumor cells to admixed peri- 
toneal cells given in parentheses. 
combination, were ineffective when admixed with the tumor inoculum, as was 
normal serum injected intraperitoneally shortly before tumor grafting. 
Cultured Macrophages as Effectors.--To identify the peritoneal exudate cells 
(induced by beef broth)  that restore suppressive capacity, macrophages were 
isolated by cell culture. The cultures contained 99.5 %  macrophages and 0.5 % 378  LYMPHOMA  GRAFT  SUPPRESSION 
lymphocytes,  in  contrast  to  the  93%  macrophages  and  7%  lymphocytes  of 
uncultured cells. The cultured macrophages did restore suppressive capability 
in irradiated mice (Fig.  1 C). 
Restoration with Cells from Irradiated Donors.--Mice  receiving thioglycollate 
intraperitonealty were given 500  R  whole body  irradiation 5  days  later.  The 
TABLE I 
Peritoneal Cells Admixed  with the Tumor-Antibody  Inoculum  Restore the Ability of Irradiated 
Mice to Suppress  Tumor Isografts 
Admixed normal donor  cells*  Anti-  Tumor size on day ll:~ 
Host  serum 
No. per  irradiated  mixed  No. of 
Type  inoculum  (500 R)  with  mice  Mean calf 
with  diameter ±  s~  (X  10  5)  tumor*  tumor~+ 
mm 
None  0  --  --  5  9.7  ±  0.45 
None  0  --  +  0  4.8  4-  0.04 
None  0  +  --  5  I0.8  4-  0.69 
None  0  +  +  5  10.8  4-  0.57 
Peritoneal  9  +  --  5  12.5  4-  0.36 
Peritoneal  9  +  +  0  5.1  4-  0.02 
PC-BIB  4  +  --  4  10.0  +  1.14 
PC-BIB  4  +  +  1  5.3  4-  0.48 
PC-TGL  10  +  -  5  10.1  4-  0.46 
PC-TGL  10  +  +  0  4.9  4-  0.08 
Spleen  10  +  +  5  11.0  4-  0.34 
Lymph node  10  +  +  5  12.0  4-  0.37 
Thymus  10  +  +  5  12.7  4-  0.57 
Bone marrow  i0  +  +  5  10.2  4-  0.40 
Thymus,  bone marrow  10 each  +  +  5  11.6  4-  0.40 
Spleen, thymus, bone marrow,  2.5 of each  +  +  5  10.7  4-  0.48 
lymph node, normal serum  cell type, 
0.4 ml se- 
rum i.p. 
* PC-BIB, peritoneal  cells from exudate  induced  by beef infusion broth; PC-TGL, peri- 
toneal  cells from exudate  induced  by thioglycollate;  cells admixed with 105 tumor cells per 
inoculum. Antiserum  diluted  1/2.5 in HBG. 
:~ Five females per group. 
exudate was harvested 20 hr after irradiation; it contained 99.5 % macrophages 
and 0.5 %  lymphocytes. Similarly induced exudate of nonirradiated mice con- 
tained  91%  macrophages  and  9%  lymphocytes.  Both  groups  of  cells  were 
about  equally tumor  suppressive  in  irradiated  hosts  when  admixed with  the 
tumor-antibody inoculum (Fig. 1 D). 
Exudate  ceils  harvested  4  days  after  an  intraperitoneal  injection  of  beef 
broth  were  also  checked  for  radiosensitivity.  A  group  of  donors  was  given 
500  R  whole body irradiation  20  hr before cell harvest.  Cells from irradiated SHIN~  KALISS~ BORENSTEIN,  AND  GATEL¥  379 
mice (95 % macrophages, 5 % lymphocytes) were as competent as those of non- 
irradiated  donors  (81%  macrophages,  18%  lymphocytes,  1%  polymorpho- 
nuclear leukocytes) in effecting tumor suppression in irradiated hosts. 
DISCUSSION 
We have found that  antibody was  not suppressive for 6C3HED  grafts  in 
irradiated  C3HeB  mice despite  the  presence of normal  or elevated levels of 
complement (2). The present study demonstrates  that various types of peri- 
toneal cells or highly purified macrophages admixed with sensitized tumor cells 
restore suppressive capacity of irradiated mice. Apparently, macrophages par- 
ticipate in antibody-mediated graft suppression. 
Tsoi and Weiser  (4)  reported that  allogeneic grafts of the strain A  tumor 
sacroma I in irradiated C57BL/Ks mice could be suppressed by starch-induced 
C57BL/Ks peritoneal exudate cells in the presence of C57BL/Ks anti-sarcoma 
I  serum. Peritoneal cells from immune mice were more effective. The exudate 
cells  were not further characterized and other cell types were not examined. 
Other investigators have shown the participation of macrophages (5) or normal 
lymphocytes (reviewed in 6) in vitro in antibody-mediated target cell destruc- 
tion. 
Though only macrophages in our experiments restored suppressive capacity, 
a  requisite for other cell  types is  not precluded.  Should such  cells  be radio- 
resistant, an effective number could have survived radiation in the tumor host. 
Moreover, since our adoptive cell transfer was in the tumor inoculum site, we 
have not entertained the question of how macrophage precursors are recruited 
in the normal animal  and how they differentiate and arrive at the graft site. 
Other cell types may- participate in these events. 
It would seem paradoxical that irradiated mice can be "restored" by peri- 
toneal cells from irradiated donors, thus indicating that these cells are radio- 
resistant.  The incapacity of irradiated mice may be attributed to: (a)  radio- 
sensitive macrophage precursors; or  (b)  an  as yet unidentified radiosensitive 
factor(s) which is needed for optimal macrophage function; or (c)  both cate- 
gories  (a)  and  (b) may be operative. Studies in progress are directed toward 
"reconstituting" irradiated animals systemically rather than locally to further 
define the host effectors in graft rejection. 
Our conclusion that an intact complement system is not required for graft 
suppression by antibody and  that macrophages are involved in this reaction 
is based on experience with a limited number of murine tumors. Whether this 
is true also for other murine tumors or for species other than the mouse or what 
general significance various host factors may have in a graft situation remains 
to be determined. 
SUMMARY 
Specific alloantibody admixed with a grafted murine lymphoma is suppressive 
of  the  graft  in  mice  of  the  inbred  strain  native  to  the  tumor.  Suppressive 380  LYMPHOMA  GRAFT  SUPPRESSION 
capacity of  the  host is obviated in mice given 500  R  whole body irradiation 
before tumor inoculation but is restored when normal peritoneal macrophages 
are admixed with  the  tumor-antibody inoculum.  Other  normal  cell types ad- 
mixed  with  the  tumor-antibody  inoculum  are  not  effective  in  restoring  sup- 
pressive capacity. 
We are indebted to Dr. Manfred M. Mayer and Dr. Moon L. Shin for their helpful advice, 
and to Mr. Stephen  Langley and Mr. Michael Hayden for their skillful technical assistance. 
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